Corticosteroid‐responsive interstitial pneumonitis related to imantinib mesylate with successful rechallenge, and potential causative mechanisms
- 10 February 2005
- journal article
- Published by Wiley in Internal Medicine Journal
- Vol. 35 (2) , 136-137
- https://doi.org/10.1111/j.1445-5994.2004.00757.x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Severe acute interstitial pnuemonia and gefitinibLung Cancer, 2004
- Interstitial pneumonia induced by imatinib mesylate: pathologic study demonstrates alveolar destruction and fibrosis with eosinophilic infiltrationLeukemia, 2004
- Imatinib Mesylate-Induced Interstitial PneumonitisMayo Clinic Proceedings, 2003
- Challenging Problems in Advanced MalignancyJournal of Clinical Oncology, 2003
- Practical Management of Patients With Chronic Myeloid Leukemia Receiving ImatinibJournal of Clinical Oncology, 2003
- Adverse cutaneous reactions to imatinib (STI571) in Philadelphia chromosome-positive leukemias: A prospective study of 54 patientsJournal of the American Academy of Dermatology, 2003
- Severe acute interstitial pneumonia and gefitinibPublished by Elsevier ,2003
- Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal TumorsNew England Journal of Medicine, 2002
- Platelet-derived growth factor β receptor regulates interstitial fluid homeostasis through phosphatidylinositol-3′ kinase signalingProceedings of the National Academy of Sciences, 1999
- Acute lung injury. Pathogenesis of intraalveolar fibrosis.Journal of Clinical Investigation, 1991